Lack of association between AQP4 polymorphisms and risk of inflammatory demyelinating disease in a Korean population

Gene

Volumn 536, Issue 2, 2014, Pages 302-307

  Park, Tae Joon ^a   Kim, Jeong Hyun ^a   Kim, Ho Jin ^b   Bae, Joon Seol ^c   Cheong, Hyun Sub ^d   Park, Byung Lae ^d   Shin, Hyoung Doo ^a,d  

^a Sogang University   (South Korea)

^b National Cancer Center   (South Korea)

^c Samsung Medical Center   (South Korea)

^d SNP Genetics Inc   (South Korea)

Author keywords

AQP4; Inflammatory demyelinating disease; Multiple sclerosis; Neuromyelitis optica; Single nucleotide polymorphism

Indexed keywords

AQUAPORIN 4; AQUAPORIN 4 ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; OPTIC NEURITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RISK FACTOR; SCHOOL CHILD; SELECTION BIAS; SINGLE NUCLEOTIDE POLYMORPHISM; UNTRANSLATED REGION; YOUNG ADULT;

AQP4; AQUAPORIN 4; CENTRAL NERVOUS SYSTEM; CNS; IDD; INFLAMMATORY DEMYELINATING DISEASE; MS; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; NMO; SINGLE NUCLEOTIDE POLYMORPHISM; SNP;

ADULT; AQUAPORIN 4; ASIAN CONTINENTAL ANCESTRY GROUP; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84892441076     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.12.007     Document Type: Article

References (38)

1. Ban M., Walton A., Goris A., et al. Polymorphisms in the neuromyelitis optica auto-antigen AQP4 and susceptibility to multiple sclerosis. J. Neurol. 2007, 254:398-399.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Canellas A.R., Gols A.R., Izquierdo J.R., Subirana M.T., Gairin X.M. Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 2007, 49:393-409.
4. Crane J.M., Rossi A., Gupta T., Bennett J.L., Verkman A.S. Orthogonal array formation by human aquaporin-4: examination of neuromyelitis optica-associated aquaporin-4 polymorphisms. J. Neuroimmunol. 2011, 236:93-98.
5. Cross D.S., Ivacic L.C., Stefanski E.L., McCarty C.A. Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. BMC Genet. 2010, 11:51.
6. Ding L., Baye T.M., He H., et al. Detection of associations with rare and common SNPs for quantitative traits: a nonparametric Bayes-based approach. BMC Proc. 2011, 5(Suppl. 9).
7. Hafler D.A., Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 2007, 357:851-862.
8. Hannoun S., Bagory M., Durand-Dubief F., et al. Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis. PLoS One 2012, 7:e32525.
9. Hinson S.R., Romero M.F., Popescu B.F., et al. Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:1245-1250.
10. Jarius S., Wildemann B. AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat. Rev. Neurol. 2010, 6:383-392.
11. Kenealy S.J., Pericak-Vance M.A., Haines J.L. The genetic epidemiology of multiple sclerosis. J. Neuroimmunol. 2003, 143:7-12.
12. Kim H.J., Park H.Y., Kim E., et al. Common CYP7A1 promoter polymorphism associated with risk of neuromyelitis optica. Neurobiol. Dis. 2010, 37:349-355.
13. Kim S.H., Kim W., Li X.F., Jung I.J., Kim H.J. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology 2012, 78:1179-1185.
14. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
15. Lennon V.A., Wingerchuk D.M., Kryzer T.J., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
16. Li J., Verkman A.S. Impaired hearing in mice lacking aquaporin-4 water channels. J. Biol. Chem. 2001, 276:31233-31237.
17. Li J., Patil R.V., Verkman A.S. Mildly abnormal retinal function in transgenic mice without Muller cell aquaporin-4 water channels. Invest. Ophthalmol. Vis. Sci. 2002, 43:573-579.
18. Lu D.C., Zhang H., Zador Z., Verkman A.S. Impaired olfaction in mice lacking aquaporin-4 water channels. FASEB J. 2008, 22:3216-3223.
19. Mai W., Hu X., Lu Z., et al. Preliminary study on the association of AQP4 promoter polymorphism with anti-aquaporin-4 antibody positivity in Southern Han Chinese patients with idiopathic demyelinating disorders of central nervous system. J. Neuroimmunol. 2012, 255:75-80.
20. Matiello M., Schaefer-Klein J.L., Hebrink D.D., et al. Genetic analysis of aquaporin-4 in neuromyelitis optica. Neurology 2011, 77:1149-1155.
21. *0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens 2009, 73:171-176.
22. Menashe I., Rosenberg P.S., Chen B.E. PGA: power calculator for case-control genetic association analyses. BMC Genet. 2008, 9:36.
23. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130:1224-1234.
24. Nicchia G.P., Ficarella R., Rossi A., et al. D184E mutation in aquaporin-4 gene impairs water permeability and links to deafness. Neuroscience 2011, 197:80-88.
25. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., et al. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J. Neurosci. 1997, 17:171-180.
26. Oh J., Levy M. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol. Res. Int. 2012, 2012:460825.
27. Opdal S.H., Vege A., Stray-Pedersen A., Rognum T.O. Aquaporin-4 gene variation and sudden infant death syndrome. Pediatr. Res. 2010, 68:48-51.
28. Papadopoulos M.C., Verkman A. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012, 11:535-544.
29. Park J.H., Gail M.H., Weinberg C.R., et al. Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18026-18031.
30. Patsopoulos N.A., Esposito F., Reischl J., et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 2011, 70:897-912.
31. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
32. Rash J.E., Yasumura T., Hudson C.S., Agre P., Nielsen S. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:11981-11986.
33. Sinclair C., Kirk J., Herron B., Fitzgerald U., McQuaid S. Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter. Acta Neuropathol. 2007, 113:187-194.
34. Sorani M.D., Zador Z., Hurowitz E., et al. Novel variants in human Aquaporin-4 reduce cellular water permeability. Hum. Mol. Genet. 2008, 17:2379-2389.
35. Suresh K., Chandrashekara S. Sample size estimation and power analysis for clinical research studies. J. Hum. Reprod. Sci. 2012, 5:7-13.
36. Wang H., Zhong X., Wang K., et al. Interleukin 17 gene polymorphism is associated with anti-aquaporin 4 antibody-positive neuromyelitis optica in the Southern Han Chinese-a case control study. J. Neurol. Sci. 2012, 314:26-28.
37. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
38. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol. 2007, 6:805-815.